2026 Annual Meeting | Industry Therapeutic Update from Amgen: Advancing Care in gMG Through a Novel Treatment Approach

Date Monday 04/20/26

Time 11:45 AM - 12:45 PM CDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Topic(s) General Neurology

Learning Objectives Join us for a presentation on how advances in the understanding of pathophysiology of generalized myasthenia gravis have enabled the development of a novel therapy. This session will review the mechanistic rationale and emerging clinical evidence informing treatment strategies and patient care.

CME Available No CME available

Event Timeline
11:45 AM - 12:45 PM CDT	Speaker	Industry Therapeutic Update from Amgen: Advancing Care in gMG Through a Novel Treatment Approach

��ɫ��

��ɫ��